Clinical trial NCT04142918: Diagnostic Markers of Neuropathic Odontalgia
Official title: Diagnostic Markers of Neuropathic Odontalgia : Proof of Concept Study
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Oral Mucosa
Keywords: painful post-traumatic trigeminal neuropathy
neuropathic pain
neuropathic odontalgia
gingival biopsy
Lead sponsor: Assistance Publique - Hôpitaux de Paris
Sponsor class: OTHER
First posted: 2019-10-29
Enrollment: 45
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: patients requiring an oral/dental surgical intervention that will generate gingival/mucosal tissue elimination (as part of the normal surgical procedure)

Brief summary: The DIAMOND study aims to investigate the presence and diagnostic relevance of potential biomarkers of the blood-nerve barrier disruption as surrogate markers of painful post-traumatic trigeminal neuropathic pain in patients presenting with neuropathic odontalgia. The first part of the study explores the proof-of-concept and technical feasibility of intra-epithelial nerve fiber immunostaining in gingival/oral mucosa biopsies and the potential presence of these biomarkers in healthy patients (baseline condition).

Detailed description: Painful Post-Traumatic Trigeminal Neuropathy (PPTTN) defines a neuropathic painful condition affecting the orofacial region, following local nerve trauma, usually secondary to dental treatments (tooth avulsion, root canal treatments....). It often presents as odontalgia of atypical presentation, unresponsive to conventional treatments. The diagnostic is often complex (and often is a diagnosis of elimination), leading to unnecessary iatrogenic dental treatments and insufficient pain relief.

This study aims to explore potential new markers of PPTTN, based on a translational approach following previous preclinical work that showed the importance of the disruption of the blood-nerve barrier in generating post-traumatic neuropathic pain. Several markers of such disruption have been highlighted (such as Claudin-5, Patched-1 and Frizzled-7) that could be specifically downregulated in neuropathic pain conditions (as compared to inflammatory neuritis conditions). As such, these markers could be interesting biomarkers of neuropathic pain. This study aims to explore the presence (and absence) of such markers in healthy vs neuropathic patients respectively.

The first part of the study investigates the technical feasibility of intra-epithelial nerve fiber staining in oral mucosa/gingiva specimens collected in healthy patients (undergoing routine oral surgery procedures) and the immunoreactivity/presence of such biomarkers in those specimens.

Eligibility criteria: Inclusion Criteria:

Adult patients (over 18 years old) requiring an oral/dental surgical intervention that will generate gingival/mucosal tissue elimination (as part of the normal surgical procedure)

Exclusion Criteria:

* Patient with a diagnosed odontalgia
* Patient with Painful Post-Traumatic Trigeminal Neuropathy (PPTTN)
* Patient with unexplained pains or a neuropathic pain regardless of its location
* Patient under guardianship or trusteeship
* Patient who refuses to give his/her non-opposition to participate to the study

Primary outcomes:
measure: Patched-1 Western Blot concentration
timeFrame: Baseline
measure: Patched-1 immunohistochemistry concentration
timeFrame: Baseline
measure: Patched-1 ELISA concentration
timeFrame: Baseline
measure: Frizzled-7 Western Blot concentration
timeFrame: Baseline
measure: Frizzled-7 immunohistochemistry concentration
timeFrame: Baseline
measure: Frizzled-7 ELISA concentration
timeFrame: Baseline
measure: Claudin-5 Western Blot concentration
timeFrame: Baseline
measure: Claudin-5 immunohistochemistry concentration
timeFrame: Baseline
measure: Claudin-5 ELISA concentration
timeFrame: Baseline
Secondary outcomes:
Other outcomes:
Locations:
city: Paris
country: France
facility: Bretonneau Hospital
Study officials:
affiliation: Assistance Publique - Hôpitaux de Paris
name: Nathan MOREAU, DDS, PhD
role: PRINCIPAL_INVESTIGATOR
References: